Abstract
The draft genome sequence of the parasitic flatworm Schistosoma mansoni (S. mansoni), a cause of schistosomiasis, encodes a predicted guanosine triphosphate (GTP) binding protein tagged Smp_059340.1. Smp_059340.1 is predicted to be a member of the G protein alpha-s subunit responsible for regulating adenylyl cyclase activity in S. mansoni and a possible drug target against the parasite. Our structural bioinformatics analyses identified key amino acid residues (Ser53, Thr188, Asp207 and Gly210) in the two molecular switches responsible for cycling the protein between active (GTP bound) and inactive (GDP bound) states. Residue Thr188 is located on Switch I region while Gly210 is located on Switch II region with Switch II longer than Switch I. The Asp207 is located on the G3 box motif and Ser53 is the binding residue for magnesium ion. These findings offer new insights into the dynamic and functional determinants of the Smp_059340.1 protein in regulating the S. mansoni life cycle. The binding interfaces and their residues could be used as starting points for selective modulations of interactions within the pathway using small molecules, peptides or mutagenesis.
Keywords: adenylyl cyclase pathway, biomarkers, GTP binding, novel drug targets, protein domain interactions, pathway regulation, Schistosoma, switch I, switch II
Introduction
Schistosoma mansoni (S. mansoni) is a dioecious trematode and one of the etiologic agents of schistosomiasis, the second most significant tropical disease after malaria of public health significance.1 The endemicity of this neglected tropical disease of poverty still remains high with about 200 million people affected worldwide (http://www.who.int/ctd/schisto/epidemio.htm). The urinary manifestation of schistosomiasis can become bladder cancer.2 Praziquantel (PZQ) is the most effective and acceptable drug against schistosomiasis, but its effectiveness is limited due to its inability to kill parasite stages within 2 to 4 weeks post-infection. Resistance to praziquantel has been observed in some S. mansoni isolates from endemic regions in Africa.3,4 The availability of the draft genome sequence of S. mansoni5 and the wealth of basic molecular biology research presents new opportunities to identify schistosome protein drug targets, and to subsequently determine drug exploitable distinctive protein structural features. The purpose of the reported research was to determine drug exploitable distinctive structural features of the Smp_058340.1 protein, which has been identified as an attractive drug target in the S. mansoni genome.6
The life cycle of S. mansoni starts with the eggs in urine or feces found in water, which then hatch to produce miracidia.7,8 The miracidia will eventually penetrate the snail tissue and transform into sporocysts. The sporocysts in the snail will develop into cercariae, which are then released into the water. The cercaria penetrates human skin, loses its tail during this process, and transforms into schistosomulum. Schistosomulum enters the blood stream and migrates to the liver, bladder and intestines and matures into an adult worm. The adults mate and produce eggs, which are released from the body through urine or feces to restart the life cycle.8
During this complex developmental cycle in the mammalian host, the juvenile parasites pursue a systematic and complicated transition that goes through the heart, lungs and finally reaches the hepatic portal system, which is the typical residence of the adult worm.8,9 This programmed movement is essential for the continuous survival of the schistosome.9 Furthermore, the movement is highly coordinated by both the organism’s neuromuscular system and the participation of a host-derived signal (serotonin (5-hydroxytryptamine: 5HT) that modulates schistosome motility.9,10 Schistosoma species have been documented to take up 5HT from their immediate host circulatory system through a transporter-mediated mechanism.11,12 This carrier mechanism is thought to contribute massively to the control of the schistosome motility in the host blood system and is very essential for the continuous survival of the parasite9,13 and thus its pathogenicity. The effects of serotonin have been extensively studied in some members of the platyhelminthes group such as Hymenolepis diminuta9,14 and S. mansoni.9,15,16
Serotonin alters the parasite muscular tone,10 strength12 and carbohydrate metabolism.14,17,18 In the intramolluscan larval stages, serotonin elevates the muscular activity of the mother sporocysts of S. mansoni,12 leading to stimulation and release of the daughter sporocysts19 and eliciting turning behavior in miracidia.20 The 5HT binds directly to the exposed surface 5HT receptor (Smp_126730) on the parasite muscles and then activates adenylyl cyclase activity, whose main function is the regulation of cyclic adenosine monophosphate (cAMP) of the anaerobic glycolysis pathway. This metabolic pathway is the main source of energy in the parasite.7,8,14 The binding of guanosine triphosphate (GTP) to the S. mansoni 5HT receptor Smp_126730 is necessary for serotonin activation.21 The adult stage of the parasite has the highest adenylyl cyclase activity, while the cercariae stage has a very low adenylyl cyclase activity,22 and the schistosomula activation is comparable to that of the adult parasite.23 The serotonin receptor undergoes a series of activated pathways while carrying out its function. The receptor-activated G proteins are bounded to the inner surface of the cell membrane.
Generally, G proteins are known to serve as mediators between signal receptors and effector enzymes. As such, they are regarded as regulator of metabolic pathways. The G protein complex is made up of the Gα and the Gβγ subunits and subunit has a functional role in controlling the activity of adenylyl cyclase. The Gα is further divided into 4 subclasses: Gαs, Gαi, Gαq/11, and Gα12/13. The Gαs subclass is the G protein component responsible for regulating the adenylyl cyclase activity pathway in S. mansoni. The binding of serotonin to the extracellular receptor triggers the release of GDP from the Gαs subunit and initiates the binding of GTP.24 This serotonin binding causes the Gβγ complex to dissociate from the Gαs-GTP complex. The activated Gαs can stimulate the adenylyl cyclase activity, while the Gβγ complexes can either stimulate or inhibit it. The Gαs-GTP complex will stimulate the adenylyl cyclase activity through the enzyme binding site of the Gαs protein. The adenylyl cyclase activity will finally lead to the production of cAMP from ATP. The process involves removing the pyrophosphatase group from ATP. This metabolic pathway is the main source of energy in the S. mansoni throughout its developmental stages.7,8,14
The GTP-binding protein Smp_059340.1 has been identified as an attractive drug target in the S. mansoni genome.6 The availability of diverse structural bioinformatics tools provides opportunities to determine the structure-function relationship of the Smp_059340.1. The G (GTP binding) proteins have fingerprints called consensus sequences (G motifs) that have served as valuable tools in their identification. However, any subtle change in these consensus sequences will be reflected in functional differences among these proteins. It is therefore very important to determine the distinctive structural features of the Smp_059340.1 protein that map to its biological function in S. mansoni.
The purpose of the reported research investigation was to determine the distinctive structural features regulating the functioning of Smp_059340.1 protein at the molecular level. We hypothesized that determining the physicochemical features and conserved protein domain organization of the S. mansoni Smp_059340.1 protein would help identify putative new functional biomarkers and regulatory points of the parasite adenylyl cyclase activity. The impact of conserved domains and their interaction was considered to be crucial for understanding the biological network of the pathway control by Smp_059340.1.
The structural bioinformatics research on the possible characteristic features, structural model and function of the Smp_059340.1 protein revealed that it is stable and hydrophilic, carrying a net positive charge on its surface which might have antigenic properties. The quality of the modeled Smp_059340.1 structure measured in terms of reliability using the QMEAN score4 range was 0.68, and the Ramachandran plot analysis indicated that 95.72% (320 residues) of the model residues were located in the core or favored region. As such, the predicted model could be assumed to be of good quality and biologically informative. According to the reliability of the modeled protein structure, the key residues regulating Smp_059340.1 function were predicted to be Ser53, Thr188, Gly210 and Asp207 respectively.
Methods
Sequence retrieval, amino acid and physicochemical parameters analysis
The S. mansoni smp_059340.1 (UniProt identification (ID): C4QDC7|C4QDC7_SCHMA; Entrez Gene ID: Smp_059340.1) reviewed sequence was retrieved from Swiss-Prot database (http://expasy.org/sprot/). The amino acid composition of the sequence was computed using the ProtParam tool (http://www.expasy.ch/cgi-bin/protparam). The ProtParam tool was also used to compute the physicochemical parameters such as theoretical isoelectric point (Ip), molecular weight, total number of positive and negative residues, extinction coefficient, half-life, instability index, aliphatic index and grand average hydropathy (GRAVY). The percentages of hydrophobic and hydrophilic residues were calculated from the primary structure analysis and the hydrophobicity plot was created using both Hopp-Woods and Kyte-Doolottle scales for possible antigenicity.
Prediction of secondary structure elements and conserved domains
The SOPMA tool (http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_sopma.html) was used for the secondary structure prediction. The TMPRED server (http://www.ch.embnet.org/software/TMPRED_form.html) performed the identification of possible transmembrane helix regions. The predicted transmembrane helices region was visualized and analyzed using helical wheel plots generated by the program Pepwheel (http://emboss.bioinformatics.nl/cgi-bin/emboss/pepwheel), included in the EMBOSS 2.7 suite.
The possible conserved domain search was carried out using the public server at http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi for the Smp_059340.1, and the individual domains present were analyzed and binding residues were compared within the domains.
Homology modeling and visualization of 3D structure
The three-dimensional (3D) structure of the Smp_059340.1 encoded protein was modeled using the PDB template 1TL7C (chain C). The 3D structure of the Smp_059340.1 protein was generated using the SwissModel server (http://swissmodel.expasy.org/) and the Phyre/Phyre2 server (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=news).
The quality of the model was evaluated with Ramachandran plot data, based on the phi–psi torsion angles of all the residues in the model using Ramachandran plot2 assessment server (http://dic-soft1.physics.iisc.ernet.in/rp/) and RAMPAGE server (http://mordred.bioc.cam.ac.uk/~rapper/rampage.php). The Rasmol tool (http://www.openrasmol.org/) was used to visualize the modeled 3D structures and to identify any possible “SS” bonds including the distribution of the secondary structures.
The three-dimensional (3D) LigandSite residue(s) and the predicted ligand(s) of the Smp_059340.1 protein were determined using 3DLigandSite server at (http://www.sbg.bio.ic.ac.uk/3dligandsite). The Rasmol tool was further used in locating the positions of the conserved domains and the keys residues involved in regulatory mechanism on the 3D and folded structure. Particularly the key residues involved in its regulatory mechanism. With the Rasmol tool, the actual locations of all domains were mapped on the protein 3D structure and folded structure.
Results
Amino acid content and physicochemical parameters
The analysis of amino acid content and physicochemical parameters suggests that Smp_059340.1 is moderately hydrophilic, due to the presence of high polar amino acid residues (50.7%) against non-polar (hydrophobic) amino acids residues (34.95%) in the sequence (Table 1). The protein is made up of 379 amino acid residues, with 20 amino acids present in the primary structure, constituting an average molecular weight of 44045.5 Da. The present analysis indicates that there are a large proportion of leucine (Leu), glutamate (Glu), lysine (Lys), arganine (Arg), isoleucine (Ile) and serine (Ser) in that order (Table 1). The atomic composition (6191) consists of 1961 carbons (C), 3093 hydrogen (H), 547 nitrogen (N), 573 oxygen (O) and 17 sulfur atoms, with a molecular formula of C1961H3093 N547O573S17 (Table 2). The 17 sulfur atoms were made up of 11 cysteine (Cys) and 6 methionine (Met) residues present in the primary structure.
Table 1.
Amino acid | Composition (%) | Hydrophilic (%) | Hydrophobic (%) |
---|---|---|---|
Ala | 6.1 | 6.1 | |
Arg | 7.4 | 7.4 | |
Asn | 5.8 | 5.8 | |
Asp | 5.8 | 5.8 | |
Cys | 2.9 | ||
Gln | 3.2 | 3.2 | |
Glu | 8.2 | 8.2 | |
Gly | 4.2 | 4.2 | |
His | 2.1 | 2.1 | |
Ile | 7.2 | 7.2 | |
Leu | 9.2 | 9.2 | |
Lys | 7.9 | 7.9 | |
Met | 1.6 | ||
Phe | 5.3 | ||
Pro | 2.9 | 2.9 | |
Ser | 6.1 | 6.1 | |
Thr | 4.2 | 4.2 | |
Trp | 1.1 | ||
Tyr | 3.7 | ||
Val | 5.3 | 5.3 | |
Total | 100.0 | 50.7 | 34.9 |
Notes: The composition of each amino acid residue is indicated as a percentage. The composition of hydrophilic amino acids is 50.7% while hydrophobic amino acids constitute 34.9%. The protein can be described as moderately hydrophilic.
Table 2.
ProtParam parameters | Values |
---|---|
No. of amino acids | 379 |
Molecular weight | 44045.5Da |
Theoretical pI | 8.51 |
Number of negative charge residues | 53 |
Number of positive charge residues | 58 |
Formula | C1961H3093N547O573S17 |
Extinction coefficient | 43485 m−1 cm−1 |
Estimated half life | 30 hours |
Instability index | 48.15 |
Aliphatic index | 82.17 |
Grand average of hydropathicity (GRAVY) | −0.458 |
Total number of atoms | 6191 |
Notes: The physicochemical parameters define the protein chemical and physical properties in its native state. Smp_059340.1 has a net positive charge and is basic in nature (pI > 7).
The computed Isoelectric point (pI) was 8.51 (pI > 7), indicating that this protein is basic in nature. The ProtParam extinction coefficient, at a wavelength of 280 nm measured in water, is favorable because proteins have stronger absorption capabilities at this wavelength than other substances commonly found in the solution. The extinction coefficient for this protein was computed with respect to Cys, tryptophan (Trp) and tyrosine (Tyr) as they were present in the primary structure. The estimated half-life of this protein with Met as the N-terminal of the sequence was 30 (>20) hours. The predicted instability index was 48.15 and 82.17 for aliphatic index, with a very low GRAVY index of −0.458. The Hopp-Woods scale identified three regions on this polypeptide predicted to be highly hydrophilic. The hydrophilic regions are shown to have peak values greater than 0 (Fig. 1), which is an indication that Smp_059340.1 could be drug target for schistosomiasis.
Secondary structure characterization
The SOPMA tool at Expasy (http://expasy.org/tools/) was used to predict secondary structures (Table 3). The data presented here indicates that this protein has mixed secondary structures made up of alpha helix (Hh) (54.62%), extended strand (Ee) (11.35%), beta turn (Tt) (4.75%) and random coil (Cc) (29.29%). The high alpha helix content may be due to the rich alanine and other hydrophobic alpha helix residues, like the phenylalanine (Phe), Leu and Ile content of the protein (Table 1). The TMPRED server at Expasy (http://expasy.org/tools/) predicted possible trans-membrane helices, with two possible orientation models (Table 4). The first model, which is strongly preferred based on a total score of 1345, suggests that the N-terminus of the protein is inside and that the region starts from the amino acid residue 218–237, spanning a total length of 20 amino acid residues in an inside → outside (i → o) orientation. The alternative model suggests an outside → inside (o → i) orientation spanning 23 amino acid residues from position 219–241, with a lower score of 854. According to the prediction accuracy of the server, the protein has trans-membrane helices in an outside → inside orientation. The transmembrane regions are rich in hydrophobic amino acids, while the hydrophilic regions are predicted as potential antigenic segments.
Table 3.
Secondary structures | Representation | Composition (%) |
---|---|---|
Alpha helix | Hh | 54.62 |
Extended stand | Ee | 11.35 |
Beta turn | Tt | 4.75 |
Random coil | Cc | 29.29 |
Notes: Secondary structure composition in percentages for Smp_059340.1 were computed using the SOPMA server at Expasy (http://expasy.org/tools/). The secondary structure elements are composed of four units (alpha helix, extended strand, beta turns and random coil). The structure is made up of more alpha helices and fewer beta turns.
Table 4.
Parameter | inside → outside (i → o) | outside → inside (o → i) |
---|---|---|
Length in amino acid position | 218–837 (20 residues) | 219–241 (23 residues) |
Score | 1345 | 854 |
Orientation preference | Strong (++) | Weak (+) |
Notes: Possible transmembrane region and orientation identified by TMPRED server at Expasy (http://expasy.org/tools/). Two transmembrane orientations were predicted. The protein strongly preferred inside → outside (i → o) orientation base on a total score of 1345 with 20 amino acid residues spanning residues 218–237. The alternative model suggest an outside → inside (o → i) orientation spanning 23 amino acid residues from position 219–241 with a lower score of 854.
The transmembrane regions are rich in hydrophobic amino acids. This region is well indicated within the Kyte and Dolittle average hydrophobicity plot of the protein residues (Fig. 1), in which all points were shown to have values above the 0 line. On the same plot (Fig. 1) the Hopp-Woods scale predicts the potential antigenic regions of the protein. The hydrophilic regions have values greater than 0, and they are predicted as potential antigenic regions. On the Kyte-Dolittle plot, regions with values less than 0 are hydrophilic in nature. Hence the antigenic regions of proteins are hydrophilic. The transmembrane helices predicted using the prediction of transmembrane region and orientation (TMPRED) server were visualized with the Pepwheel tool (Fig. 2) using the 20 amino acids in an inside → outer orientation. The residues in the blue square (I, L, V) and the violet residues (C, A, W, F, Y) represent the hydrophobic amino acids while those in diamond (red) are the acidic residues (polar residues; N, T, S, D, Q).
Conserved domain and functional analysis of Smp_059340.1
The Conserved Domain search at the National Center for Biotechnology Information (NCBI) website revealed 12 functional units and their full residues (Table 5). The conserved domain search for Smp_059340.1 revealed 12 functional domains scattered within its amino acids sequence length (Fig. 3, Table 5). Close observation of Table 5 shows that these functional units share many residues in common, suggesting that the Smp_059340.1 protein functions as a highly interconnected network of functional units. The next sections provide descriptions of the structural and functional domain interactions of the overall regulatory mechanism of the adenylyl cyclase pathway that controls the general developmental processes of the schistosome.
Table 5.
Conserved domain | Component residue(s) | Function |
---|---|---|
Mg2+/GTP binding site | G46, G51, K52, S53, T188, D207, G210, N276, K277, D279, C350, A351 | The Mg2+ interacts with alpha subunits of the G proteins in the present of GTP to form a complex from which nucleotide dissociate slowly |
Adenylyl cyclase interaction site | I191, R216, I219, Q220, N223 | Stimulates the adenylyl cyclase by binding to it |
Beta—gamma complex interaction site | S189, I191, E193, H204, F206, G210, Q211, R212, E214, K217, W218, Q220, C221, F222, N223 | The beta/gamma complex can also stimulate and inhibit the adenylyl cyclase activity, but no model of its function had been established |
GoLoco binding site | A47, G48, E49, D77, K81, D85, C88, A91, G92, R112, I115, I156, R185, G210, W218, F222 | It binds Gαi/o/GDP complex and prevents the spontaneous release of GDP by Gα, thus acting as a guanine nucleotide dissociation inhibitor (GDI) |
Putative receptor binding site | H342, Y343, C344, Y345, P346, H347, L348, T349, C350, A351, V352, D353, E355, N356, I357, R358 | Binds the protein to the serotonin receptor (Smp_126730) |
Switch I region | R183, C184, R185, V186, L187, T188, S189, G190, I191 | Molecular switches (called the effector loop) |
Switch II region | V208, G209, G210, Q211, R212, E213, E214, R215, R216, K217, W218, I219, Q220, C221, F222, N223, D224 | Molecular switches |
G1 box motif | G46, A47, G48, E49, S50, G51, K52, S53 | GTP binding signature |
G2 box motif | T188 | Involved in Mg2+ coordination |
G3 box motif | D207, V208, G209, G210 | Links the subsites for binding of Mg2+ and the γ phosphate of GTP (GTP γ- phosphate- binding site) |
G4 box motif | N276, K277, Q278, D279 | Recognizes the guanine ring |
G5 box motif | C350, A351, V352 | Buttresses the guanine base recognition site |
Notes: In the Schistosoma mansoni protein Smp_059340.1, each of the residues contributing to the function of each domain in the complex network is presented. Most domains share residues with each other making the network very complex at atomistic level.
The Smp_059340.1 modeled 3D structural analysis and verification
The crystal structure of S. mansoni C4QDC7_SCHMA (Smp_059340.1) has not yet been determined; here we present the 3D homology model structure of the protein using chain C (1TL7C) as a template with 93% of the residues modeled at a 90% confidence level, as analyzed using the Phyre/Phyre2 server (Fig. 4A). The statistics of Smp_059340.1 (target) and the template showing their comparison was derived from the SwissModel server (Table 6). Residue 39 to 373 of Smp_059340.1 was aligned with the template, covering 88% of its entire sequence length. Irrespective of the length difference between the template and the target, they both share 70% sequence identity. The quality of the model was measured using the QMEAN score4. The QMEAN score4 measures the global score of the whole model, reflecting the predicted model reliability range from 0 to 1. The modeled Smp_059340.1 structure had QMEAN score4 value of 0.68, suggesting that it is a good, biologically informative model.
Table 6.
Model information | Value |
---|---|
Modeled residue aligned range | 39 to 373 |
Target sequence length | 378 |
Template sequence length | 402 |
Template | 1TL7C (2.80 Å) |
Sequence identity | 70.00% |
Target aligned coverage | 88.00% |
E value | 1.15e-133 |
Model quality | QMEAN score4: 0.68 |
Ligand (s) in template | GSP:1, MG:1 |
Notes: Residues 39 to 373 of Smp_059340.1 were aligned with the template, covering 88.00% of its entire sequence length with 70.00% sequence identity. A QMEAN score4 value of 0.68 suggests the model could be of good quality and can be biologically informative.
The Swiss model server estimate per residue inaccuracy was visualized based on secondary structural components. The color gradient ranges from blue (more reliable region) to red (potential unreliable regions; Fig. 4B). A greater proportion of unreliable regions were located around the loops and random coils, which are usually the most difficult parts to predict. The sequence alignment of the template and Smp_059340.1 (target) generated by HMM-HMM matching using the Phyre/Phyre2 server shows that the alpha helices and beta strands were predicted with approximate better confidence values than the random coil (Fig. 5A). Further comparison between the template and Smp_059340.1 (target) using structural superposition helped to establish the regions of the model, which agree and disagree (Fig. 5B). As with every model, the agree regions are trustworthy while disagree regions are generally treated with caution when making biological inferences.25
We further evaluated the quality of the model using the Ramachandran plot on the web (2.0)26 (Fig. 6A) and RAMPAGE server27 (Fig. 6B). The Ramachandran plot had been widely used for assessing the quality of predicted models based on the phi-psi torsion angles of all the residues.25,26,28–30 The fully-allowed and additionally-allowed regions from the Ramachandran plot on the web (2.0), together, are equivalent to the favored (core) region of the RAMPAGE server. In addition, the generously allowed region from the Ramachandran plot on the web (2.0) is equivalent to the allowed region from the RAMPAGE server (Fig. 6A and B). The Ramachandran plot analysis indicates that 95.72% of the model residues (76.56% fully allowed + 19.16% additionally allowed) are located in the core or favored region, 2.99% in the allowed region and 1.2% in the outside region, also known as the outlier or high energy region (Fig. 6C). Residues in the high energy region are considered unstable and can compromise the quality of a modeled structure.31 A good quality model is expected to have over 90% of the residues in the core region.26,29,30 This indicates that the Smp_059340.1 predicted model with 320 residues in the core region could be of good quality and biologically informative.
The Rasmol tool was used to visualize the modeled tertiary structure of the Smp_059340.1 protein. The secondary structure components are composed of 20 helices, 8 sheets, 35 turns and 3158 hydrogen bonds. The helices are represented in red, sheets in yellow and turns in blue. The white or grayish colored regions near the turns are other secondary structures (Fig. 7).
GTP/Mg2+ ion binding site domain
The distribution of the GTP/Mg2+ ion complex binding site residues (green) indicates that they are located on the loops, helices and the β sheets (Fig. 8A). On the protein folded structure these residues are situated in the active site (fold) of the protein that extends to the outer side, through a hollow cavity cutting across the protein internal structure (Fig. 8B). The GTP/Mg2+ ion binding site shares four common residues with the G1 box motif at Gly46, Gly51, Lys52 and Ser53 (Table 5). The GTP/Mg2+ ion binding site converges at two plastic regions of switch I (G2 box motif-threonine (Thr)188) and switch II (Gly210; Table 5). The GTP/Mg2+ ion binding site also shares some conserved residues with the G3 box motif at aspartate (Asp)207, and with the G4 box motif at residue asparagine (Asn)276, Lys277 and Asp279 (Table 5).
Adenylyl cyclase interaction site domain
The adenylyl cyclase interaction site consists of 5 residues made up of Ile191, Arg216, Ile219, glutamine (Gln)220, and Asn223 (black; Fig. 8A), which binds and stimulates adenylyl cyclase activities. The distribution of the adenylyl cyclase interaction site residues (black) indicates that they are located on the loops and helices only (Fig. 8A). On the protein folded structure these residues are localized on the surface of the protein (Fig. 8A). This approximate surface location might be a natural structural orientation to provide efficiency in recognition and binding of the adenylyl cyclase enzyme, leading to stimulation of the adenylyl cyclase pathway during the various developmental phases of S. mansoni. The adenylyl cyclase interaction site shared 4 out of its 5 residues (Arg216, Ile 219, Gln220 and Asn223) with the switch II region and three residues (Ile191, Gln220 and Asn223) with the beta-gamma complex binding site (Table 5). This interaction indicates that the adenylyl cyclase interaction site is totally coupled to the beta-gamma complex, and that it is almost completely embedded in the switch II region. As such, the adenylyl cyclase binding site might be contributing to the conformation changes that occur during functioning of the switch II region.
Beta-gamma complex interaction site and GoLoco binding site domains
The beta-gamma residues (green) are located on the helix, loop and β sheets, and they share common residues (Gly210, Trp218 and Phe222; blue) with the GoLoco binding site on the loop and helix (Fig. 9A). Within the protein folded structure, the beta-gamma complex site (green) is positioned on the surface (Fig. 9B), in close proximity to the location of the GTP/Mg2+ ion complex binding site through residue Gly210. At the adenylyl cyclase interaction site the beta-gamma complex site interconnect at residue Ile191, Gln220 and Asn223, while at the GoLoco binding site, the beta-gamma complex site shares residue Gly210, Trp218 and Phe222 shown in blue (Fig. 9B).
The GoLoco binding site (black) has residues located on the helices and the loops (Fig. 9A). It is situated in close proximity to the location of switch I, switch II and the beta-gamma binding site (Fig. 9B), where it can influence their activities independently due their common shared residues as explained above. The GoLoco binding site also shares conserved residues with the GTP/Mg2+ ion complex site and the G3 box motif.
Putative receptor binding site domain
The putative receptor conserved residues (red) are positioned on a loop and helix (Fig. 10A). On the protein-folded structure, the receptor binding site (red) stretches from within the inner active cavity where it shares two residues with the GTP/Mg2+ ion complex binding site at Cys350 and Ala351 to the surface of the protein (Fig. 10B). It also shares all 3 conserved residues (Cys350, Ala351 and valine (Val)352) found in G5 box motif. Hence the G5 box motif is part of the putative receptor binding site, and functions as a buttress factor for the guanine base recognition site.
Switch I and switch II region domains
The switch I residues (green) are located on the loop and helix, while switch II residues (yellow) are also situated on the loop and helix. Both molecular switches cycle between an active state (GTP bound) and an inactive state (GDP bound; Fig. 8A). Our analysis shows that both switches are located on the outer surface of the protein, with switch I shorter than the switch II region by 8 residues (Table 5, Fig. 10B). These regions share conserved residues with the GTP/Mg2+ ion complex, adenylyl cyclase interaction site, beta-gamma complex, GoLoco binding site and the G2 box motif (Table 5) as explained above. On the folded protein structure the switch I region (green) is orientated on the surface, very close to the switch II region (yellow; Fig. 10B). The switch II is another region responsible for the conformation changes between the GTP and the GDP as stated above. This switch II region shares conserved residues with GTP/Mg2+ ion complex, adenylyl cyclase interaction site, beta-gamma complex, GoLoco binding site and the G3 box motif (Table 5). We deduced that both the adenylyl cyclase binding site (4 out of 5 residues) (Arg216, Ile219, Gln220 and Asn223) and the G3 box motif (3 out of 4 residues) (Val208, Gly209, Gly210) are completely integrated into the switch II region in terms of their shared residues.
G1-G5 box motif domains
The G protein superfamily folds in different variations depending on its nucleotide binding folds.32 There are five polypeptide loops that form the guanine nucleotide-binding site, and all have well-conserved elements in their domain. They are used for defining the G protein superfamily. These loops are labeled G1 box-G5 box.33 All five loops were present in this protein structural view (Fig. 11A). The G1 box motif (GxxxxGK(S/K); red) has been mentioned above in connection with the GTP/Mg2+ ion binding site, and it is located on the loop, sheet and helix (Fig. 11A). It is used for defining GTP binding proteins in general.33 The G2 box motif (green) is located on the loop and contains only one residue, being Thr188. Only the Thr188 is conserved throughout the superfamily, but surrounding residues are conserved within the families. The G2 box motif is part of GTP/Mg2+ ion complex and switch I region.
The G3 box motif (Black) is also known as the DxxG consensus sequence34–36 and is situated on the loop and sheet, which function to link the sub-sites for binding the Mg2+ ion with the γ phosphate of the of GTP. It also shares some common conserved residues with the GTP/Mg2+ ion complex, beta-gamma complex, GoLoco binding site and the switch II region (Table 1) as mentioned above. The G3 box motif is also known as the Walker B motif37 and forms an integral part of the switch II region. The G4 box motif (NKXD; yellow) is localized on the loop, helix and sheet. The main function of the G4 box motif is to recognize the guanine ring. The G5 box motif ([C/S]A[K/L/T]; blue) functions as a booster to the guanine base recognition site. It shares one conserved residue (Ala351) with the GTP/Mg2+ ion binding site and all 3 residues with the putative receptor binding site. Hence, it is part of the putative receptor binding site (Table 4). The protein folded structure indicates that all five loops (G1 box-G5 box) are located in the active fold (Fig. 11B). The G2 box motif (green) is embedded in the active cavity of the protein, very close to G3 box motif (black) with G4 box motif (yellow) situated very close to G5 box motif (blue).
Ligand binding site
The predicted ligand binding analysis shows that at the GTP/Mg2+ ion complex site, the Mg2+ ion binds to Ser53 and the metallic ligand is well embedded in the active cavity (Fig. 12). This ligand binding indicates that irrespective of the residues coordinating the GTP binding at GTP/Mg2+ ion complex site, Ser53 could be considered crucial in regulating the adenylyl cyclase pathway in S. mansoni developmental cycles.
Discussion
Physicochemical properties of the S. mansoni Smp_059340.1 protein
The Smp_059340.1 protein regulating adenylyl cyclase pathway in Schistosoma mansoni development can be described as moderately hydrophilic and basic in nature (Table 1). The hydrophobic residues are usually found in the core of most proteins and they help stabilize the proteins during their numerous van der Waal interactions.38 The hydrophilic residues are located mostly at the surface active sites of the proteins, where they interact with other polar residues in the protein or with water molecules. The pI indicates the pH at which the protein surface is covered with charge,39 and the net charge of Smp_059340.1 is positive. The high number of positive charged residues (Arg + Lys = 58) against the total number of negatively charged residues (Asp + Glu = 53) is the main contributing factor to the positive charge. pI proteins are generally stable and compact, thus this parameter will be useful for developing buffer systems for purification of this protein by isoelectric focusing techniques.39 The high extinction coefficient of 43485 M−1 cm−1 at 280 nm wavelength computed for Smp_059340.1 was due to the individual contributions of Cys (2.9%), Trp (1.1%) and Tyr (3.7%) concentrations respectively. This observation suggests that the Smp_059340.1 protein can be analyzed using a UV spectrum assay protocol.40 The computed protein concentration and the extinction coefficient could be important in the quantitative analysis of the protein-protein and protein-ligand interactions of this protein in solutions.40,41
The estimated half-life of this protein with Met as the N-terminal of the sequence was 30 (>20) hours. The high concentrations of Ala (6.1%), Leu (9.2%) and Val (5.3%) may be contributing to the stability of this protein.42,43 The half-life of these 3 residues has been well documented in mammals with values of Ala (4.4 hours), Leu (5.5 hours) and Val (100 hours). In other organisms, these residues also contribute to the protein stability. In yeast, the half life was the same (>20 hours) for both Ala and Val, as well as in Escherichia coli, with values > 10.44
The instability index prediction using the ProtParam tool indicates that Smp_059340.1 may be unstable with a value of 48.15. This parameter was computed from the impact of dipeptides in the protein sequence.45 However, Smp_059340.1 is shown to have high aliphatic index and half-life, and enough hydrogen atoms (3093) to form hydrogen bonds. Such hydrogen bonds are known to impact protein stability significantly, making them resistant to degradation.46 Therefore, it appears that the formation of hydrogen bonds in Smp_059340.1 may override the impact of dipeptides. The calculated value is a measure of protein stability in a test tube.45 A protein of instability index < 40 is considered as stable, while those with values > 40 are unstable.45
The aliphatic index (AI) of a protein is the relative volume occupied by the aliphatic side chains (Ala, Val, Ile, and Leu) and is considered a contributor to the increased thermal stability of globular proteins. The aliphatic index computed for Smp_059340.1 was 82.17, using a formulated rule.47 This high aliphatic index indicates that Smp_059340.1 can be stable within a wide temperature range. Proteins with low thermal stability turn out to be more structurally flexible.
The Grand Average of Hydropathy (GRAVY) is the computed sum of hydropathy values of all the amino acids, divided by the number of residues in the sequence.48 The very low GRAVY index (−0.458) of Smp_059340.1 indicates that there is good interaction between this protein and water. The Hopp-Woods scale identified three regions on this polypeptide predicted to be highly hydrophilic. Hydrophilic regions are exposed on the surface and may possibly represent antigenic sites,49 indicating that this protein can serve as a possible drug target for schistosomiasis.
Interactions of domain-specific amino acids at the Smp_059340.1 protein active sites
The presence of conserved domain active sites within the guanine nucleotide-binding proteins (G proteins) is responsible for many important biological functions within the cellular process of an organism.36,50 These functions range from signal transduction, protein synthesis, cell proliferation, protein targeting, membrane trafficking and secretion, including cell skeletal organization and movement.51–53 The sharing of functional unit residues among domains suggests that the Smp_059340.1 functions as a highly interconnected network of functional domains, as will be explained below.
GTP/Mg2+ ion binding site interaction
The distribution of the GTP/Mg2+ ion complex binding site residues and their orientation to the active fold may be seen as a native adaptation for efficient binding of the GTP molecule. The Mg2+ ion interacts with alpha subunits of the G proteins in the presence of GTP to form a complex, from which nucleotides dissociate slowly at multiple sites. Higher concentrations of the Mg2+ ion have been documented to promote the dissociation of GDP.54 The dissociation of nucleotides at multiple sites could be accounted by the stretch of active fold observed in Figure 8A. The GTP is bounded as a complex with the Mg2+ ion through the coordination of one oxygen atom from the γ-phosphate, as Gαs proteins are known to be unstable in the absence of a bounded nucleotide.55 The binding sites for both Mg2+ ion and GTP are strongly linked together.54 We found that the GTP/Mg2+ ion binding site shares four common residues with the G1 box motif at residues Gly46, Gly51, Lys52 and Ser53 (Table 5). The G1 box motif is one of the five polypeptide loops that form the guanine nucleotide-binding site with well-conserved elements in the domain. It is also called the Walker A motif, and has been used to define the G protein superfamily and its ability to bind guanine nucleotide such as GTP.33 The shared residues between the GTP/Mg2+ ion binding site and the G1 box motif could account for the binding of GTP at the GTP/Mg2+ ion binding site domain.
We also found that the GTP/Mg2+ ion binding site converged at two plastic regions of switch I (G2 box motif-Thr188) and switch II (Gly210; Table 5). The coupling between the GTP-γ-phosphate site and the Mg2+ ion may be accounted for by the rigidity of the switch I/switch II interface.56 The key residue could be Thr188, which binds the magnesium ions of the Mg-GTP complex, allowing it to sense the presence of the γ- phosphate found in GTP molecules. The GTP/Mg2+ ion binding site also shares some conserved residues with the G3 box motif at Asp207 (Table 5). The conserved Asp207 residue in the G3 box motif also coordinates the Mg2+ ion through a water molecule. This coordination could also be crucial for the tight linkage of both the Mg2+ ion and the GTP binding sites. In the GTP/Mg2+ ion complex, the ligand bonds are contributed to by both the β and γ phosphates of the GTP molecule, as well as by Thr188 and the water molecules.
The Asp207 in the G3 box motif binds to one of the water molecules in the process. There is also possible hydrogen bond formation with the α-phosphate oxygen atom from the GTP molecule. The GTP/Mg2+ ion binding site also shares some common residues with the G4 box motif (Asn276, Lys277 and Asp279; Table 5). The G4 box motif functions to recognize the guanine ring, suggesting that the Mg-GTP complex binding site can be regarded as the initiating point for the adenylyl cyclase metabolic pathway. The methylene group of the common Lys277 residue of both the GTP/Mg2+ ion complex binding site and the G4 motif might be providing the hydrophobic surface that lies over the purine ring57 during the binding process.
Beta-gamma complex and GoLoco binding interaction site
On the protein folded structure, the beta-gamma complex site is positioned on the surface in close proximity to the location of the GTP/Mg2+ ion complex binding site, adenylyl cyclase interaction site and GoLoco binding site. This closeness helps both the beta-gamma complex and the GoLoco site in influencing the activity of the GTP/Mg2+ ion complex binding site, the adenylyl cyclase interaction site and the switch II region respectively. However, the beta-gamma complex can stimulate and inhibit adenylyl cyclase activity.58 This inhibition might be through the common shared residues (Ile191, Gln220 and Asn223) with the beta-gamma complex, although no model for this function had been established. The beta-gamma complex also shares Gly210 with the G3 box motif. There is a possible hydrogen bond formation between the γ-phosphate of GTP and the main chain amide of the conserved Gly210 in the G3 box. The stimulation or inhibition of adenylyl cyclase activity may be linked to Gly210 residue, considering its function during the binding of the GTP/Mg2+ ion complex. The beta-gamma complex also shares two residues (Ser189 and Ile189) with switch I, and 10 residues (Gly210, Gln211, Arg212, Glu214, Lys217, Trp218, Gln220, Cys221, Phe222 and Asn223) with switch II (Table 1). This residue sharing suggests that the beta-gamma complex might influence the conformation changes exhibited by both switches, which could affect adenylyl cyclase activity. The GoLoco binding site is known to act as a guanine nucleotide dissociation inhibitor (GDI),59 and this could account for how it might inhibit adenylyl cyclase activity.
The beta-gamma complex interaction site shares conserved residues with many other domains (Table 5). Its functions had been extensively covered in the sections above regarding how it might influence the activity of the other domains together with the GoLoco motif binding site. The binding of extra-cellular hormone (5HT) on the S. mansoni serotonin receptor (Smp_126730) initiates the ejection of GDP from the G-alpha subunit and initiates the binding of GTP to the G-alpha subunit.24 This binding causes the disassociation of G-alpha subunit from the G-alpha/beta-gamma complex. Within the protein folded structure the beta-gamma complex site (green) is positioned on the surface, suggesting that the beta-gamma complex is also in close proximity to the location of switch I and switch II, where it might influence their functions. This closeness might help both the beta-gamma complex and the GoLoco sites to influence the activity of both switches through their shared residues.
The GoLoco binding site (black) has residues located on the helices and the loops (Fig. 9A). It is situated in close proximity to the location of switch I, switch II and the beta-gamma binding site (Fig. 9B), where it might influence their activities independently due their common shared residues, as explained above. The GoLoco binding site also shares conserved residues with GTP/Mg2+ ion complex site and G3 box motif. The GoLoco binding site is also known as the G protein regulatory (GPR) motif,60 and it is known to prevent the spontaneous release of GDP by Gαs, thus acting as a guanine nucleotide dissociation inhibitor (GDI).59 We have discussed in the previous sections how this domain influences the activities of other domains with shared residues, and we shall look at its impact with the rest of the uncovered individual domains.
Putative receptor, switch I and switch II interaction sites
On the protein folded structure, the receptor binding site stretches from within the inner active cavity were it shares two residues with the GTP/Mg2+ ion complex binding site at Cys350 and Ala351 to the surface of the protein (Fig. 10B). It also shares all 3 conserved residues (Cys350, Ala351 and Val352) found in G5 box motif. Hence, the G5 box motif is part of the putative receptor binding site and functions as a buttress factor for the guanine base recognition site. Ala351 could be contributing to this buttress factor function due to its presence at the GTP/Mg2+ ion complex binding site. The structural conformity of the putative receptor might be contributing to the binding stability of the Gαs (Smp_059340.1) protein, the GTP molecule and to the serotonin receptor (Smp_126730). Considering the function, conserved shared residues and location of the putative receptor binding site, this domain can be very crucial to the continuous flow of signal in the adenylyl cyclase pathway.
Switch I and switch II are both molecular switches cycling between an active state (GTP bound) and an inactive state (GDP bound), and switch I is shorter than switch II by 8 residues. These regions share conserved residues with the GTP/Mg2+ ion complex, adenylyl cyclase interaction site, beta-gamma complex, GoLoco binding site and the G2 box motif as explained above. In switch I, the transitional conformation changes mainly involve flips of some peptide units and reorientation of some side chains.61,62 The key residue could be the Thr188 that coordinates the magnesium ions of the Mg-GTP complex, which can thus sense the presence of the γ phosphate.63 Therefore, the conformation transition in the switch I region is manifested in a reorientation of the conserved residue (Thr188) in both the Mg2+ ion ligand and the G2 box motif (Thr188), which is also an integral residue of the switch I region. The switch I region has also been identified as the GAP (GTP activation protein) binding region.64,65 This region may be responsible for the tight coupling of the GTP/Mg2+ ion complex through their shared Thr188 residue.56 As explained in the previous paragraphs, the function of the switch I region during conformation changes between GTP and GDP can be compromised by both the beta-gamma complex and the GoLoco binding sites, through their common shared conserved residues (Table 5). On the folded protein structure, the switch I region (green) is oriented on the surface, very close to the switch II region (yellow; Fig. 10B). As mentioned above, the beta-gamma complex or the GoLoco binding sites share common conserved residues with both switch I and switch II regions. Therefore, this close proximity of switch I and switch II region suggests that the conformational changes in both switches might be coupled with, and the functionality of both switches might be influenced simultaneously by, either the beta-gamma complex or the GoLoco binding sites.
The switch II shares conserved residues with the GTP/Mg2+ ion complex, adenylyl cyclase interaction site, beta-gamma complex, GoLoco binding site and the G3 box motif. It was deduced that both the adenylyl cyclase binding site (4 out of 5 residues) and the G3 box motif (3 out of 4) residues are completely integrated into the switch II region in terms of the their shared residues. There is considerable conformational flexibility in this region, especially in the GDP bound state.61,62 As mentioned above, the adenylyl cyclase binding site may be contributing to these conformation changes. The same plausible reason as explained above for the switch II region could be the case here—the conformational changes between GTP and GDP can be greatly hampered by both the beta-gamma complex and the GoLoco binding sites through their common shared conserved residues. The switch II influences the tight coupling of the GTP/Mg2+ ion complex through the shared Gly210 with DxxD near the N-terminal end of the switch II helix.66 In this superfamily, the binding energy of GTP is normally used to stabilize switch regions, so that a conformation is produced that favors its association with an effector. The switch II region is relatively mobile at the effector binding region, particularly in the GTP bound form. Gly220 in switch II and DxxD (Table 5) might be the determining point for the reorientation and partial refolding of the helical region of switch II61 due to its contribution to forming a hydrogen bond with the gamma-phosphate, as mentioned above.61
However, there is a slight difference in structural position between switch I and switch II regions (Fig. 10 A). Both are located on the protein surface, but the switch II (yellow) residues are oriented outwards, while the switch I (green) residues form part of the active site (fold) of the protein, and are localized at the gateway of the active site of the protein. The Thr188 shared between the GTP/Mg2+ ion complex and switch I region may account for differences in the active site location. The GTP/Mg2+ ion binding site residues are located in the active cavity of the protein (Fig. 8B).
G1-G5 box motif interaction sites
The G1 box motif is used to define GTP binding proteins in general.33 Only the G2 box residue Thr188 is conserved throughout the superfamily, but surrounding residues are conserved within the families. As mentioned above, its main function is to coordinate the magnesium ions of the Mg-GTP complex, which can thus sense the present of the γ-phosphate. The function of the Thr188 had been elaborated extensively in both the GTP/Mg2+ ion complex and the switch I sections above. The conserved Asp207 residue in the G3 box motif coordinates the Mg2+ ion through a water molecule, and the conserved Gly220 in the switch II and in the G3 box motif determines the reorientation and partial refolding of the helical region of switch II61 by forming a hydrogen bond with the γ-phosphate.61 The G3 box motif is also known to form an integral part of the switch 2 region. All five loops (G1-G5) are located in the active fold, with the G4 box motif situated very close to G5 box motif. The plausible reason for this may be that the G5 box motif buttresses the guanine base recognition site. The residue Ala351 may be the booster component in guanine site recognition. The location of the five loops in the cavity indicates their importance in the binding of GTP molecules (Fig. 11B).
Conclusion
We have elucidated the distinctive characteristic features of the S. mansoni Smp_059340.1 protein, a predicted drug target, from its primary structure to learn how these features contribute to the functioning and regulation of the developmental process in the schistosome’s life cycle. However, because these distinctive characteristic features are predictions, they should be considered with caution. The protein is basic and moderately hydrophilic, carrying a net positive charge with possible antigenic properties on its surface. Smp_059340.1 is predicted to be stable within a wide range of temperature, with a high possibility of being analyzed using a UV spectrum assay protocol. Further, Smp_059340.1 is a soluble protein consisting of mixed secondary structure features, with the transmembrane helices having an inside → outside orientation.
The quality of the modeled Smp_059340.1 structure, measured in terms of reliability using the QMEAN score4 range, was 0.68. The Ramachandran plot analysis indicates that 95.72% (320 residues) of the model residues are located in the core or are favored. As such, the predicted model can be assumed to be of good quality and biologically informative. With respect to the reliability of the modeled protein structure, the key features controlling GTP binding and effective pathway regulations were found to be Thr188, Gly210, Asp207 and Ser53. Analysis of the protein domain organization revealed that the pathway regulated by this protein is very complex, and that these domains are interconnected through shared conserved residues regulating the network.
These findings offer new insights into the dynamic and functional determinants of the Smp_059340.1 protein in regulation of the life cycle pathway. These conspicuous structural and functional biomarkers in the Smp_058340.1 encoded protein will add impetus in biological experimental design, particularly site–directed mutagenesis experiments regulating the pathway control by this gene during the developmental stages of the S. mansoni.
We envision that by following this type of approach, the distinctive functional features and the derived 3D model can provide a simplistic understanding of important biological issues, such as how protein domains interact at a molecular level in a network. The modeled binding interfaces and their residues could be used as starting points to guide selective modulations of interactions within the pathway using small molecules, peptides, or mutagenesis.
Footnotes
Funding
National Institutes of Health: Research Centers in Minority Institutions (RCMI)—Center for Environmental Health at Jackson State University (NIH-NCRR 2G12RR013459); Mississippi IDeA Network for Biomedical Research Excellence (NIH-NCRR-P20RR016476 and NIH-NIGMS- 8P20GM103476); Bioinformatics Programs in Minority Institutions (1T36GM095335); National Center for Integrative Biomedical Informatics (U54DA021519). National Science Foundation: Mississippi NSF-EPSCoR Grant Award (EPS-0903787 and EPS 1006883); Undergraduate Research and Mentoring Program (DBI-0958179) and Visual Analytics in Biology Curriculum Network (DBI-1062057). US Department of Homeland Security Science and Technology Directorate (2009-ST-062-000014; 2011-ST-062-000048).
Competing Interests
Author(s) disclose no potential conflicts of interest.
Author Contributions
Conceived and designed the experiments: ANM, RDI Analyzed the data: ANM, RDI. Wrote the first draft of the manuscript: ANM. Contributed to the writing of the manuscript: RDI, HLK, ORA. Agree with manuscript results and conclusions: ANM, RDI, HLK, ORA. Jointly developed the structure and arguments for the paper: ANM, RDI, HLK, ORA. Made critical revisions and approved final version: ANM, RDI, HLK, ORA. All authors reviewed and approved of the final manuscript.
Disclosures and Ethics
As a requirement of publication author(s) have provided to the publisher signed confirmation of compliance with legal and ethical obligations including but not limited to the following: authorship and contributorship, conflicts of interest, privacy and confidentiality and (where applicable) protection of human and animal research subjects. The authors have read and confirmed their agreement with the ICMJE authorship and conflict of interest criteria. The authors have also confirmed that this article is unique and not under consideration or published in any other publication, and that they have permission from rights holders to reproduce any copyrighted material. Any disclosures are made in this section. The external blind peer reviewers report no conflicts of interest.
References
- 1.Borch M, Kiernan M, Rust K, et al. Schistosomiasis: a case study. Urol Nurs. 2009;29(1):26–9. [PubMed] [Google Scholar]
- 2.Brindley PJ, Mitreva M, Ghedin E, Lustigman S. Helminth genomics: The implications for human health. PLoS Negl Trop Dis. 2009;3(10):e538. doi: 10.1371/journal.pntd.0000538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Melman SD, Steinauer ML, Cunningham C, et al. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis. 2009;3(8):e504. doi: 10.1371/journal.pntd.0000504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Doenhoff MJ, Kusel JR, Coles GC, Cioli D. Resistance of Schistosoma mansoni to praziquantel: is there a problem? Trans R Soc Trop Med Hyg. 2002;96(5):465–9. doi: 10.1016/s0035-9203(02)90405-0. [DOI] [PubMed] [Google Scholar]
- 5.Berriman M, Haas BJ, LoVerde PT, et al. The genome of the blood fluke Schistosoma mansoni. Nature. 2009;460(7253):352–8. doi: 10.1038/nature08160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Crowther GJ, Shanmugam D, Carmona SJ, et al. Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl Trop Dis. 2010;4(8):e804. doi: 10.1371/journal.pntd.0000804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gobert GN, Moertel L, Brindley PJ, McManus DP. Developmental gene expression profiles of the human pathogen Schistosoma japonicum. BMC Genomics. 2009;10:128. doi: 10.1186/1471-2164-10-128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Jolly ER, Chin CS, Miller S, et al. Gene expression patterns during adaptation of a helminth parasite to different environmental niches. Genome Biol. 2007;8(4):R65. doi: 10.1186/gb-2007-8-4-r65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Patocka N, Ribeiro P. Characterization of a serotonin transporter in the parasitic flatworm, Schistosoma mansoni: cloning, expression and functional analysis. Mol Biochem Parasitol. 2007;154(2):125–33. doi: 10.1016/j.molbiopara.2007.03.010. [DOI] [PubMed] [Google Scholar]
- 10.Pax RA, Siefker C, Bennett JL. Schistosoma mansoni: differences in acetylcholine, dopamine, and serotonin control of circular and longitudinal parasite muscles. Exp Parasitol. 1984;58(3):314–24. doi: 10.1016/0014-4894(84)90048-1. [DOI] [PubMed] [Google Scholar]
- 11.Wood PJ, Mansour TE. Schistosoma mansoni: serotonin uptake and its drug inhibition. Exp Parasitol. 1986;62(1):114–9. doi: 10.1016/0014-4894(86)90014-7. [DOI] [PubMed] [Google Scholar]
- 12.Boyle JP, Zaide JV, Yoshino TP. Schistosoma mansoni: effects of serotonin and serotonin receptor antagonists on motility and length of primary sporocysts in vitro. Exp Parasitol. 2000;94(4):217–26. doi: 10.1006/expr.2000.4500. [DOI] [PubMed] [Google Scholar]
- 13.Ribeiro P, Webb RA. The occurrence, synthesis and metabolism of 5-hydroxytryptamine and 5-hydroxytryptophan in the cestode Hymenolepis diminuta: a high performance liquid chromatographic study. Comp Biochem Physiol C. 1984;79(1):159–64. doi: 10.1016/0742-8413(84)90179-8. [DOI] [PubMed] [Google Scholar]
- 14.Mettrick DF, Rahman MS, Podesta RB. Effect of 5-hydroxytryptamine (5-HT; serotonin) on in vitro glucose uptake and glycogen reserves in Hymenolepis diminuta. Mol Biochem Parasitol. 1981;4(3–4):217–23. doi: 10.1016/0166-6851(81)90020-7. [DOI] [PubMed] [Google Scholar]
- 15.Boyle JP, Hillyer JF, Yoshino TP. Pharmacological and autoradiographical characterization of serotonin transporter-like activity in sporocysts of the human blood fluke, Schistosoma mansoni. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2003;189(8):631–41. doi: 10.1007/s00359-003-0429-8. [DOI] [PubMed] [Google Scholar]
- 16.Gustafsson MK. Immunocytochemical demonstration of neuropeptides and serotonin in the nervous systems of adult Schistosoma mansoni. Parasitol Res. 1987;74(2):168–74. doi: 10.1007/BF00536029. [DOI] [PubMed] [Google Scholar]
- 17.Rothman RB, Glowa JR. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909. Mol Neurobiol. 1995;11(1–3):1–19. doi: 10.1007/BF02740680. [DOI] [PubMed] [Google Scholar]
- 18.Rahman MS, Mettrick DF, Podesta RB. Schistosoma mansoni: effects of in vitro serotonin (5-HT) on aerobic and anaerobic carbohydrate metabolism. Exp Parasitol. 1985;60(1):10–7. doi: 10.1016/s0014-4894(85)80018-7. [DOI] [PubMed] [Google Scholar]
- 19.Bayne CJ, Grevelding CG. Cloning of Schistosoma mansoni sporocysts in vitro and detection of genetic heterogeneity among individuals within clones. J Parasitol. 2003;89(5):1056–60. doi: 10.1645/GE-3186RN. [DOI] [PubMed] [Google Scholar]
- 20.Samuelson JC, Quinn JJ, Caulfield JP. Hatching, chemokinesis, and transformation of miracidia of Schistosoma mansoni. J Parasitol. 1984;70(3):321–31. [PubMed] [Google Scholar]
- 21.McNall SJ, Mansour TE. Novel serotonin receptors in Fasciola. Characterization by studies on adenylate cyclase activation and [3H]LSD binding. Biochem Pharmacol. 1984;33(17):2789–97. doi: 10.1016/0006-2952(84)90697-x. [DOI] [PubMed] [Google Scholar]
- 22.Shiff C, Naples JM, Isharwal S, Bosompem KM, Veltri RW. Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use? Trans R Soc Trop Med Hyg. 2010;104(1):3–5. doi: 10.1016/j.trstmh.2009.05.013. [DOI] [PubMed] [Google Scholar]
- 23.Kasschau MR, Mansour TE. Serotonin-activated adenylate cyclase during early development of Schistosoma mansoni. Nature. 1982;296(5852):66–8. doi: 10.1038/296066a0. [DOI] [PubMed] [Google Scholar]
- 24.Weitmann S, Würsig N, Navarro JM, Kleuss C. A functional chimera of mammalian guanylyl and adenylyl cyclases. Biochemistry. 1999;38(11):3409–13. doi: 10.1021/bi982229l. [DOI] [PubMed] [Google Scholar]
- 25.Kelley LA, Sternberg MJ. Protein structure prediction on the Web: a case study using the Phyre server. Nature Protoc. 2009;4(3):363–71. doi: 10.1038/nprot.2009.2. [DOI] [PubMed] [Google Scholar]
- 26.Gopalakrishnan K, Sowmiya G, Sheik SS, Sekar K. Ramachandran plot on the web (2.0) Protein Peptide Lett. 2007;14(7):669–71. doi: 10.2174/092986607781483912. [DOI] [PubMed] [Google Scholar]
- 27.Lovell SC, Davis IW, Arendall WB, 3rd, et al. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins. 2003;50(3):437–50. doi: 10.1002/prot.10286. [DOI] [PubMed] [Google Scholar]
- 28.Hooft RW, Sander C, Vriend G. Objectively judging the quality of a protein structure from a Ramachandran plot. Comput Appl Biosci. 1997;13(4):425–30. doi: 10.1093/bioinformatics/13.4.425. [DOI] [PubMed] [Google Scholar]
- 29.Porter LL, Rose GD. Redrawing the Ramachandran plot after inclusion of hydrogen-bonding constraints. Proc Natl Acad Sci U S A. 2011;108(1):109–13. doi: 10.1073/pnas.1014674107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Zhou AQ, O’Hern CS, Regan L. Revisiting the Ramachandran plot from a new angle. Protein Sci. 2011;20(7):1166–71. doi: 10.1002/pro.644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Maccallum PH, Poet R, Milner-White EJ. Coulombic attractions between partially charged main-chain atoms stabilise the right-handed twist found in most beta-strands. J Mol Biol. 1995;248(2):374–84. doi: 10.1016/s0022-2836(95)80057-3. [DOI] [PubMed] [Google Scholar]
- 32.Brändeén CI. Relation between structure and function of alpha/beta-proteins. Q Rev Biophys. 1980;13(3):317–38. doi: 10.1017/s0033583500001712. [DOI] [PubMed] [Google Scholar]
- 33.Jurnak F, McPherson A, Wang AH, Rich A. Biochemical and structural studies of the tetragonal crystalline modification of the Escherichia coli elongation factor Tu. J Biol Chem. 1980;255(14):6751–7. [PubMed] [Google Scholar]
- 34.Colicelli J. Signal transduction: RABGEF1 fingers RAS for ubiquitination. Curr Biol. 2010;20(15):R630–2. doi: 10.1016/j.cub.2010.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Field CM, Kellogg D. Septins: cytoskeletal polymers or signalling GTPases? Trends Cell Biol. 1999;9(10):387–94. doi: 10.1016/s0962-8924(99)01632-3. [DOI] [PubMed] [Google Scholar]
- 36.Pandit SB, Srinivasan N. Survey for g-proteins in the prokaryotic genomes: prediction of functional roles based on classification. Proteins. 2003;52(4):585–97. doi: 10.1002/prot.10420. [DOI] [PubMed] [Google Scholar]
- 37.Walker JE, Runswick MJ, Saraste M. Subunit equivalence in Escherichia coli and bovine heart mitochondrial F1F0 ATPases. FEBS Lett. 1982;146(2):393–6. doi: 10.1016/0014-5793(82)80960-5. [DOI] [PubMed] [Google Scholar]
- 38.Berezovsky IN, Trifonov EN. Van der Waals locks: loop-n-lock structure of globular proteins. J Mol Biol. 2001;307(5):1419–26. doi: 10.1006/jmbi.2001.4554. [DOI] [PubMed] [Google Scholar]
- 39.Sillero A, Maldonado A. Isoelectric point determination of proteins and other macromolecules: oscillating method. Comput Biol Med. 2006;36(2):157–66. doi: 10.1016/j.compbiomed.2004.09.006. [DOI] [PubMed] [Google Scholar]
- 40.Stoscheck CM. Quantitation of protein. Methods Enzymol. 1990;182:50–68. doi: 10.1016/0076-6879(90)82008-p. [DOI] [PubMed] [Google Scholar]
- 41.Gill SC, von Hippel PH. Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem. 1989;182(2):319–26. doi: 10.1016/0003-2697(89)90602-7. [DOI] [PubMed] [Google Scholar]
- 42.Bachmair A, Finley D, Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Science. 1986;234(4773):179–86. doi: 10.1126/science.3018930. [DOI] [PubMed] [Google Scholar]
- 43.Gonda DK, Bachmair A, Wünning I, Tobias JW, Lane WS, Varshavsky A. Universality and structure of the N-end rule. J Biol Chem. 1989;264(28):16700–12. [PubMed] [Google Scholar]
- 44.Varshavsky A. The N-end rule pathway of protein degradation. Genes Cells. 1997;2(1):13–28. doi: 10.1046/j.1365-2443.1997.1020301.x. [DOI] [PubMed] [Google Scholar]
- 45.Guruprasad K, Reddy BV, Pandit MW. Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng. 1990;4(2):155–61. doi: 10.1093/protein/4.2.155. [DOI] [PubMed] [Google Scholar]
- 46.Chen YW, Fersht AR, Henrick K. Contribution of buried hydrogen bonds to protein stability. The crystal structures of two barnase mutants. J Mol Biol. 1993;234(4):1158–70. doi: 10.1006/jmbi.1993.1667. [DOI] [PubMed] [Google Scholar]
- 47.Ikai A. Thermostability and aliphatic index of globular proteins. J Biochem. 1980;88(6):1895–8. [PubMed] [Google Scholar]
- 48.Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982;157(1):105–32. doi: 10.1016/0022-2836(82)90515-0. [DOI] [PubMed] [Google Scholar]
- 49.Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A. 1981;78(6):3824–8. doi: 10.1073/pnas.78.6.3824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Colicelli J. Human RAS superfamily proteins and related GTPases. Sci STKE. 2004;2004(250):RE13. doi: 10.1126/stke.2502004re13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Yamanaka G, Eckstein F, Stryer L. Interaction of retinal transducin with guanosine triphosphate analogues: specificity of the gamma-phosphate binding region. Biochemistry. 1986;25(20):6149–53. doi: 10.1021/bi00368a048. [DOI] [PubMed] [Google Scholar]
- 52.Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987;56:615–49. doi: 10.1146/annurev.bi.56.070187.003151. [DOI] [PubMed] [Google Scholar]
- 53.Birnbaumer L. Transduction of receptor signal into modulation of effector activity by G proteins: the first 20 years or so…. FASEB J. 1990;4(14):3178–88. doi: 10.1096/fasebj.4.14.2172060. [DOI] [PubMed] [Google Scholar]
- 54.Higashijima T, Ferguson KM, Sternweis PC, Smigel MD, Gilman AG. Effects of Mg2+ and the beta gamma-subunit complex on the interactions of guanine nucleotides with G proteins. J Biol Chem. 1987;262(2):762–6. [PubMed] [Google Scholar]
- 55.Ferguson KM, Higashijima T, Smigel MD, Gilman AG. The influence of bound GDP on the kinetics of guanine nucleotide binding to G proteins. J Biol Chem. 1986;261(16):7393–9. [PubMed] [Google Scholar]
- 56.Hepler JR, Kozasa T, Smrcka AV, et al. Purification from Sf9 cells and characterization of recombinant Gq alpha and G11 alpha. Activation of purified phospholipase C isozymes by G alpha subunits. J Biol Chem. 1993;268(19):14367–75. [PubMed] [Google Scholar]
- 57.Gille A, Liu HY, Sprang SR, Seifert R. Distinct interactions of GTP, UTP, and CTP with G(s) proteins. J Biol Chem. 2002;277(37):34434–42. doi: 10.1074/jbc.M204259200. [DOI] [PubMed] [Google Scholar]
- 58.Weitmann S, Schultz G, Kleuss C. Adenylyl cyclase type II domains involved in Gbetagamma stimulation. Biochemistry. 2001;40(36):10853–8. doi: 10.1021/bi011176w. [DOI] [PubMed] [Google Scholar]
- 59.Willard FS, Kimple RJ, Kimple AJ, Johnston CA, Siderovski DP. Fluorescence-based assays for RGS box function. Methods Enzymol. 2004;389:56–71. doi: 10.1016/S0076-6879(04)89004-9. [DOI] [PubMed] [Google Scholar]
- 60.Takesono A, Cismowski MJ, Ribas C, et al. Receptor-independent activators of heterotrimeric G-protein signaling pathways. J Biol Chem. 1999;274(47):33202–5. doi: 10.1074/jbc.274.47.33202. [DOI] [PubMed] [Google Scholar]
- 61.Milburn MV, Tong L, deVos AM, et al. Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science. 1990;247(4945):939–45. doi: 10.1126/science.2406906. [DOI] [PubMed] [Google Scholar]
- 62.Schlichting I, Almo SC, Rapp G, et al. Time-resolved X-ray crystallographic study of the conformational change in Ha-Ras p21 protein on GTP hydrolysis. Nature. 1990;345(6273):309–15. doi: 10.1038/345309a0. [DOI] [PubMed] [Google Scholar]
- 63.Kraulis PJ, Domaille PJ, Campbell-Burk SL, Van Aken T, Laue ED. Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy. Biochemistry. 1994;33(12):3515–31. doi: 10.1021/bi00178a008. [DOI] [PubMed] [Google Scholar]
- 64.Calés C, Hancock JF, Marshall CJ, Hall A. The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product. Nature. 1988;332(6164):548–51. doi: 10.1038/332548a0. [DOI] [PubMed] [Google Scholar]
- 65.Adari H, Lowy DR, Willumsen BM, Der CJ, McCormick F. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science. 1988;240(4851):518–21. doi: 10.1126/science.2833817. [DOI] [PubMed] [Google Scholar]
- 66.Greasley SE, Jhoti H, Teahan C, et al. The structure of rat ADP-ribosylation factor-1 (ARF-1) complexed to GDP determined from two different crystal forms. Nat Struct Biol. 1995;2(9):797–806. doi: 10.1038/nsb0995-797. [DOI] [PubMed] [Google Scholar]